We'll cut back on our Twenty-First Century Fox position in order to accumulate more shares of Starwood Hotels.
The stock's valuation is compelling, too.
If Hormel is taking the plunge into more natural and organic foods, they all have to take the plunge. That's why Hain and WhiteWave are in play.
Actavis' attractive near to medium-term organic growth profile is not reflected in current valuation levels.
We're selling all of Kinder Morgan to get into Occidental Petroleum.
TheStreet's Jim Cramer says he'll be focused on Big Lots before the opening bell Friday. That's when the discount retailer plans to report its latest quarterly results.
The new drug complements the company's offer in the field.
We should just call Wednesday's trading one big 'hair of the dog' rally.
Price to be linked to drugs' performance.
TheStreet's Jim Cramer says cellphone semiconductors is where the action is, and Avago Technologies is one of the leaders. The company reports earnings Thursday.